ArticleScientific reports2025
Optimal strategies for managing Hepatitis B Virus (HBV) infection: a comprehensive approach through education, vaccination, and therapy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Incidence and risk factors for hepatitis B virus reactivation in kidney transplant recipients: a systematic review and meta-analysis.BMC nephrology · 2026Pooled it
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B virus (HBV) is a significant health hazard in the world. This article describes a new mathematical model, which takes into account three intervention measures: education, vaccination, and therapy. The main novelty of our method is that we introduce two new compartments, an initially recovered population [Formula: see text],which counts persons with provisional immunity, and a class of reinfected [Formula: see text],of the source of immunity lost and of re-entry into the infectious pool. This framework explicitly models the clinically important interactions of waning immunity and vaccine failure using a more biologically realistic model than earlier ones which assume permanent recovery. We prove the well-posedness of the model by showing the positivity, boundedness, and stability of solutions, and obtain the basic reproduction number. [Formula: see text] applying the next-generation approach. The main aim of the given research is to develop and identify an optimal control strategy that will identify the best combination of these three interventions. We develop an optimal control model that reduces the prevalence of the infection and the costs of the intervention. Numerical modeling shows that, although each intervention has a medium effect, the most meaningful decrease in HBV prevalence occurs when the two are combined. Our results offer a sound theoretical basis to the policy of health promotion, emphasizing that the combination of multiple strategies is significantly more effective than a single one in attaining long-term control and potentially eliminating HBV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.